Delivery Order SPE2DR25D3501-SPE2DR26FM3PL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,391.95 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom on January 27, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is...
- The Defense Logistics Agency awarded a delivery order valued at $6,688.64 to AmerisourceBergen Drug Corp for 20,000 unit vials of RECOTHROM on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running...
- On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $33,704.33 to Amerisourcebergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical settings. This competitive, firm fixed-price contract is scheduled for completion by January 26, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating full and open competition among...
- This contract award is for the delivery of 20,000 unit vials of RECOTHROM, a medical product, to the Defense Logistics Agency (DLA). The firm-fixed-price contract has a ceiling value of $12,818.88 and an ultimate completion date of November 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This delivery order, valued at $2,463.48, was awarded to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Recothrom pharmaceutical product totaling 20,000 units. The contract is a firm fixed price delivery order with a completion date of December 31, 2025, issued by the Defense Logistics Agency (DLA) through its Medical Supply Chain operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a firm fixed price ceiling value of $6,998.20. The award, executed on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside contract. The contract will be fulfilled from AmerisourceBergen's operations in...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order, valued at $5,912.18, was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The order is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 20,000 unit vials of RECOTHROM, a specialty medical product. The delivery order is valued at $13,353.00 and has a firm fixed price contract type, with an ultimate completion date of November 5, 2024. The contract is a child award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order, valued at $20,512.70, was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract utilizes no set-aside designation, indicating that AmerisourceBergen competed against other qualified vendors to secure the...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.32 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM3PLDelivery Order
This delivery order, awarded on January 30, 2026, provides for the supply of 20,000 unit vials of RECOTHROM to support federal medical procurement needs. The contract is valued at $8,064.79 with a firm fixed-price structure and an ultimate completion date of February 2, 2026. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with performance taking place at the same location. No set-aside designation was used in this competitive award, and the Defense Logistics Agency funded the contract as part of its medical supply chain operations. This delivery order was executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, significant Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This primary contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in fulfilling Department of Defense medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||